- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | CHORDATE MEDICAL: Chordate's board member to "Women's health is a concern for society at large" | 1 | Cision News | ||
| 03.04. | CHORDATE MEDICAL: Chordate comments on Q4 and case report | 1 | Cision News | ||
| 12.03. | CHORDATE MEDICAL: Chordate's CEO presented at Swiss Nordic Bio | 1 | Cision News | ||
| 06.03. | Nasdaq Stockholm AB: New equity right for trading, Chordate Medical Holding AB (publ) TO8 (112/24) | 219 | GlobeNewswire | At the request of Chordate Medical Holding AB, Chordate Medical Holding equity
rights will be traded on First North Growth Market as from March 8, 2024.
Security name: Chordate Medical Holding TO... ► Artikel lesen | |
| 01.03. | Nasdaq Stockholm AB: Delisting of paid subscription units of Chordate Medical Holding AB (publ) from First North Growth Market (104/24) | 194 | GlobeNewswire | Last day of trading in paid subscription units (BTU) of Chordate Medical
Holding AB (publ) (104/24)
Trading in Chordate Medical Holding AB (publ) paid subscription units is to
cease. The last trading... ► Artikel lesen | |
| 02.02. | Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Chordate Medical Holding AB (publ) (57/24) | 593 | GlobeNewswire | With effect from February 02, 2024, the units rights in Chordate Medical
Holding AB (publ) will be traded on First North Growth Market. Trading will
continue up until and including February 13, 2024.... ► Artikel lesen | |
| 29.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 29.01.2024 | 419 | Xetra Newsboard | Das Instrument K1Z SE0009495559 CHORDATE MEDICAL HLG AB EQUITY wird cum Kapitalmassnahme gehandelt am 29.01.2024 und ex Kapitalmassnahme am 30.01.2024 The instrument K1Z SE0009495559 CHORDATE MEDICAL... ► Artikel lesen | |
| 26.01. | Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ) | 236 | GlobeNewswire (Europe) | The following resolutions was adopted at the extraordinary general meeting of Chordate Medical Holding AB (publ) held on January 26th, 2024.
Reduction of the share capital for allocation to the unrestricted... ► Artikel lesen | |
| 04.01. | CHORDATE MEDICAL: Chordate continues its marketing activities and exit strategy | 2 | Cision News | ||
| 27.12.23 | Nasdaq Stockholm AB: Change of Certified Adviser for Chordate Medical Holding AB (publ) (692/23) | 365 | GlobeNewswire | As from December 29th 2023, Chordate Medical Holding AB (publ) will change
Certified Adviser to Vator Securities AB.
This information is distributed at the request of the Certified Adviser, Västra
hamnen... ► Artikel lesen | |
| 06.12.23 | CHORDATE MEDICAL: Chordate's CSO comments on the start of the PM009 study | 1 | Cision News | ||
| 29.11.23 | CHORDATE MEDICAL: Chordate installs system in Germany and launches in the UAE | 1 | Cision News | ||
| 13.11.23 | Chordate Medical starts post-market study in four markets | 1 | Cision News |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 51,90 | +1,37 % | Siemens Healthineers: Aktie klettert im DAX - das beflügelt | Die Aktie von Siemens Healthineers sichert sich am Montag einen der Spitzenränge im DAX. Auftrieb verleihen positive News vom Konkurrenten Philips. Dessen Aktie zieht mittlerweile mit einem Plus von... ► Artikel lesen | |
| FRESENIUS | 27,950 | -0,07 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius anlässlich des Verkaufs von 67 Prozent der Vamed-Reha-Kliniken auf "Buy" mit einem Kursziel von 40 Euro belassen.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,260 | -2,34 % | Kursgewinne für die Aktie von Fresenius Medical Care (38,13 €) | Im deutschen Wertpapierhandel liegt der Anteilsschein von Fresenius Medical Care aktuell im Plus. Das Wertpapier kostete zuletzt 38,13 Euro. Freuen können sich gegenwärtig die Aktionäre von Fresenius... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 64,31 | +4,16 % | PROCEPT BioRobotics Corp - 10-Q, Quarterly Report | ||
| CARL ZEISS MEDITEC | 97,80 | +0,46 % | EQS-AFR: Carl Zeiss Meditec AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Carl Zeiss Meditec AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Carl Zeiss Meditec AG: Vorabbekanntmachung... ► Artikel lesen | |
| MOBILE-HEALTH NETWORK SOLUTIONS | 3,330 | -84,91 % | Mobile-health Retreats on Opening New Pharmacy | ||
| RXSIGHT | 61,68 | +3,44 % | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| ATRICURE | 20,890 | -5,99 % | AtriCure Reports First Quarter 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
| GERRESHEIMER | 102,00 | +0,39 % | Gerresheimer schließt Partnerschaft mit RxCap für vernetzte Adhärenz-Lösungen | Düsseldorf/Berlin/Ohio, USA (ots) - Gerresheimer schließt Partnerschaft mit RxCap für vernetzte Adhärenz-Lösungen- Gerresheimer-Tochter Centor erhält exklusive Vertriebsrechte für Apotheken in den USA-... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 18,740 | +1,79 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 11,500 | +3,98 % | BrightSpring Health Services, Inc. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Guidance | LOUISVILLE, Ky., May 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| CASTLE BIOSCIENCES | 24,330 | +6,52 % | Castle Biosciences Reports First Quarter 2024 Results | FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results... ► Artikel lesen | |
| ADAPTHEALTH | 10,260 | -0,87 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 6,630 | +26,05 % | Alignment Healthcare Reports First Quarter 2024 Results | Reports $628.6 million in total revenue and $627.6 million in revenue excluding ACO REACH, up 43.1% and 54.2% year-over-year respectivelyMedicare Advantage membership grows 50.5% year-over-year to... ► Artikel lesen | |
| MIMEDX | 7,370 | -1,73 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial Results | Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management... ► Artikel lesen |
Das Unternehmen CHORDATE MEDICAL HOLDING AB kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,000 (+18,18 %) liegt der Kurs bei 0,003 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
